268 related articles for article (PubMed ID: 27671672)
1. TAK1 knockdown enhances lipopolysaccharide-induced secretion of proinflammatory cytokines in myeloid cells via unleashing MEKK3 activity.
Li K; Wang M; Hu Y; Xu N; Yu Q; Wang Q
Cell Immunol; 2016 Dec; 310():193-198. PubMed ID: 27671672
[TBL] [Abstract][Full Text] [Related]
2. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
3. Homeostatic interactions between MEKK3 and TAK1 involved in NF-kappaB signaling.
Di Y; Li S; Wang L; Zhang Y; Dorf ME
Cell Signal; 2008 Apr; 20(4):705-13. PubMed ID: 18206350
[TBL] [Abstract][Full Text] [Related]
4. WNK1-TAK1 signaling suppresses lipopolysaccharide-induced cytokine production and classical activation in macrophages.
Arai Y; Asano K; Mandai S; Ando F; Susa K; Mori T; Nomura N; Rai T; Tanaka M; Uchida S; Sohara E
Biochem Biophys Res Commun; 2020 Dec; 533(4):1290-1297. PubMed ID: 33046244
[TBL] [Abstract][Full Text] [Related]
5. Euscaphic acid isolated from roots of Rosa rugosa inhibits LPS-induced inflammatory responses via TLR4-mediated NF-κB inactivation in RAW 264.7 macrophages.
Kim IT; Ryu S; Shin JS; Choi JH; Park HJ; Lee KT
J Cell Biochem; 2012 Jun; 113(6):1936-46. PubMed ID: 22234926
[TBL] [Abstract][Full Text] [Related]
6. TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-kappaB in lipopolysaccharide-stimulated macrophages.
Irie T; Muta T; Takeshige K
FEBS Lett; 2000 Feb; 467(2-3):160-4. PubMed ID: 10675530
[TBL] [Abstract][Full Text] [Related]
7. Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling.
Yamazaki K; Gohda J; Kanayama A; Miyamoto Y; Sakurai H; Yamamoto M; Akira S; Hayashi H; Su B; Inoue J
Sci Signal; 2009 Oct; 2(93):ra66. PubMed ID: 19843958
[TBL] [Abstract][Full Text] [Related]
8. TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation.
Blonska M; Shambharkar PB; Kobayashi M; Zhang D; Sakurai H; Su B; Lin X
J Biol Chem; 2005 Dec; 280(52):43056-63. PubMed ID: 16260783
[TBL] [Abstract][Full Text] [Related]
9. MEKK3 is essential for lipopolysaccharide-induced interleukin-6 and granulocyte-macrophage colony-stimulating factor production in macrophages.
Kim K; Duramad O; Qin XF; Su B
Immunology; 2007 Feb; 120(2):242-50. PubMed ID: 17116170
[TBL] [Abstract][Full Text] [Related]
10. The rLrp of Mycobacterium tuberculosis inhibits proinflammatory cytokine production and downregulates APC function in mouse macrophages via a TLR2-mediated PI3K/Akt pathway activation-dependent mechanism.
Liu Y; Li JY; Chen ST; Huang HR; Cai H
Cell Mol Immunol; 2016 Nov; 13(6):729-746. PubMed ID: 26166760
[TBL] [Abstract][Full Text] [Related]
11. Phosphatase holoenzyme PP1/GADD34 negatively regulates TLR response by inhibiting TAK1 serine 412 phosphorylation.
Gu M; Ouyang C; Lin W; Zhang T; Cao X; Xia Z; Wang X
J Immunol; 2014 Mar; 192(6):2846-56. PubMed ID: 24534530
[TBL] [Abstract][Full Text] [Related]
12. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
Rim HK; Cho W; Sung SH; Lee KT
J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
[TBL] [Abstract][Full Text] [Related]
13. Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.
Moon G; Kim J; Min Y; Wi SM; Shim JH; Chun E; Lee KY
Cell Signal; 2015 Dec; 27(12):2524-33. PubMed ID: 26432169
[TBL] [Abstract][Full Text] [Related]
14. TRAF6 and TAK1 Contribute to SAMHD1-Mediated Negative Regulation of NF-κB Signaling.
Espada CE; St Gelais C; Bonifati S; Maksimova VV; Cahill MP; Kim SH; Wu L
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177202
[TBL] [Abstract][Full Text] [Related]
15. S6K1 negatively regulates TAK1 activity in the toll-like receptor signaling pathway.
Kim SY; Baik KH; Baek KH; Chah KH; Kim KA; Moon G; Jung E; Kim ST; Shim JH; Greenblatt MB; Chun E; Lee KY
Mol Cell Biol; 2014 Feb; 34(3):510-21. PubMed ID: 24277938
[TBL] [Abstract][Full Text] [Related]
16. Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex.
Mendoza H; Campbell DG; Burness K; Hastie J; Ronkina N; Shim JH; Arthur JS; Davis RJ; Gaestel M; Johnson GL; Ghosh S; Cohen P
Biochem J; 2008 Feb; 409(3):711-22. PubMed ID: 18021073
[TBL] [Abstract][Full Text] [Related]
17. Propofol Inhibits Lipopolysaccharide-Induced Inflammatory Responses in Spinal Astrocytes via the Toll-Like Receptor 4/MyD88-Dependent Nuclear Factor-κB, Extracellular Signal-Regulated Protein Kinases1/2, and p38 Mitogen-Activated Protein Kinase Pathways.
Zhou CH; Zhu YZ; Zhao PP; Xu CM; Zhang MX; Huang H; Li J; Liu L; Wu YQ
Anesth Analg; 2015 Jun; 120(6):1361-8. PubMed ID: 25695672
[TBL] [Abstract][Full Text] [Related]
18. LYATK1 potently inhibits LPS-mediated pro-inflammatory response.
Xi F; Liu Y; Wang X; Kong W; Zhao F
Biochem Biophys Res Commun; 2016 Jan; 470(1):1-8. PubMed ID: 26620228
[TBL] [Abstract][Full Text] [Related]
19. Wogonin inhibits LPS-induced inflammatory responses in rat dorsal root ganglion neurons via inhibiting TLR4-MyD88-TAK1-mediated NF-κB and MAPK signaling pathway.
Chen S; Xiong J; Zhan Y; Liu W; Wang X
Cell Mol Neurobiol; 2015 May; 35(4):523-31. PubMed ID: 25504431
[TBL] [Abstract][Full Text] [Related]
20. 7b, a novel naphthalimide derivative, exhibited anti-inflammatory effects via targeted-inhibiting TAK1 following down-regulation of ERK1/2- and p38 MAPK-mediated activation of NF-κB in LPS-stimulated RAW264.7 macrophages.
Shao J; Li Y; Wang Z; Xiao M; Yin P; Lu Y; Qian X; Xu Y; Liu J
Int Immunopharmacol; 2013 Oct; 17(2):216-28. PubMed ID: 23810444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
